임상시험 트래커

추적 기업 30곳의 임상 6,982건 (국내 전체 이력 · 글로벌 진행 중). 출처: ClinicalTrials.gov

23건 표시

1/2상모집 예정· Myeloma Multiple
Etenta-Isa-VRd in Newly Diagnosed High-Risk Multiple Myeloma
협력: 애브비, 사노피
상세 →NCT07600151
단계 미표기모집 예정· Influenza Immunization
Post-marketing Surveillance Study for the Safety of Efluelda® Pre-filled Syringe
리드: 사노피
상세 →NCT07282795
단계 미표기모집 예정· Immunization
Post-marketing Surveillance Study for the Safety of Efluelda Tetra Pre-filled Syringe.
리드: 사노피
상세 →NCT06694025
3상모집 예정· Meningococcal Infection
Immunogenicity and Safety Study of an Investigational Quadrivalent Meningococcal Conjugate Vaccine Administered in Healthy Infants and Toddlers in China
리드: 사노피
상세 →NCT07710872
4상모집 예정· Chronic Graft Versus Host Disease
A Study to Investigate Safety of Belumosudil in Participants Aged 12 Years and Above, With Chronic Graft-versus-host Disease (cGVHD)
리드: 사노피
상세 →NCT07135973
단계 미표기모집 예정· COPD (Chronic Obstructive Pulmonary Disease)
The Study of Chronic Obstructive Pulmonary Disease (COPD) Participants Treated With Dupilumab (STRIDE) Registry
리드: 사노피
상세 →NCT07612878
단계 미표기모집 예정· Type 1 Diabetes (T1D)
Type 1 Diabetes Screening
협력: 사노피
상세 →NCT07612475
2상모집 예정· Gastric Cancer
A Dose Optimization/Expansion Study of SAR445877 in Adult Chinese Participants With Advanced Gastric or Gastroesophageal Junction Cancer
리드: 사노피
상세 →NCT07692204
단계 미표기모집 예정· Hemophilia a
A Prospective Assessment of Bone Health in Patients With Severe Hemophilia A on Factor VIII vs Factor Mimetic Prophylaxis (Efa Emi Bone Health Study)
협력: 사노피
상세 →NCT07582276
2상모집 예정· Dementia, Alzheimer's Type
A Study to Investigate the Safety and Effectiveness of SAR448851 in Participants With Early Alzheimer's Disease
리드: 사노피
상세 →NCT07688213
2상모집 예정· cGVHD
Belumosudil With Ruxolitnib as Second Line Therapy for Chronic Graft Versus Host Disease (cGvHD) After Steroid Failure
협력: 사노피
상세 →NCT07643025
단계 미표기모집 예정· Hemophilia A
TG-INSIGHT With Joint POCUS, Hemostatic Potential in Patients With Severe Hemophilia A on Novel Replacement and Substitution FVIII Therapies
협력: 사노피
상세 →NCT07692217
단계 미표기모집 예정· Asthma
Quantifying the Burden of Type 2 (T2) Inflammation in Asthma
협력: 사노피
상세 →NCT07675044
4상모집 예정· Chronic Obstructive Pulmonary Disease (COPD)
This After Market Study is Seeing if Dupilumab Plus Usual Standard of Care (SOC) is Better Than Usual Care Alone for Adult Participants After a Severe Chronic Obstructive Pulmonary Disease (COPD) Flare-Up Requiring Hospitalization
리드: 리제네론 · 협력: 사노피
상세 →NCT07587658
3상모집 예정· Multiple Myeloma
Determination 2 - Isatuximab, Iberdomide, Bortezomib and Dexamethasone Induction, Followed by Risk- and Response-Adapted Consolidation and Maintenance Therapy, in Transplant-Eligible Patients With Newly Diagnosed Multiple Myeloma
협력: BMS, 리제네론, 사노피
상세 →NCT07624513
해당없음모집 예정· Healthy Adult
Finding Immune Nascent Type 1 Diabetes
협력: 사노피
상세 →NCT07663136
해당없음모집 예정· Asthma Attack
Boosting Referrals to Asthma Specialists for Patients Seen at the Emergency Room for an Asthma Exacerbation
협력: 사노피
상세 →NCT07396987
단계 미표기모집 예정· Meningococcal Immunization
Post Marketing Surveillance Study for MenQuadfi® [Meningococcal (Groups A, C, Y, W) Polysaccharide Tetanus Toxoid Conjugate Vaccine] Administered in Participants Aged 6 Weeks to 55 Years in Republic of Korea
리드: 사노피
상세 →NCT07621653
3상모집 예정· Chronic Rhinosinusitis With Nasal Polyps
A Phase 3 Study to Assess the Efficacy, Safety, and Tolerability of Itepekimab (Anti-IL-33 mAb) in Adult Japanese Participants With Inadequately-controlled Chronic Rhinosinusitis With Nasal Polyps
리드: 사노피 · 협력: 리제네론
상세 →NCT07484230
해당없음모집 예정· Type 1 Diabetes (T1D)
Feasibility and Adoption of a Screening Program for T1D Relatives in Canada
협력: 사노피
상세 →NCT07322380
단계 미표기모집 예정· Acne
Non-interventional Translational Study in Mild, Moderate and Severe Acne Patients
협력: 사노피
상세 →NCT07411638
4상모집 예정· Chronic Rhinosinusitis With Nasal Polyps
Immunologic Impact of Dupilumab in Patients Suffering From Asthma and Chronic Rhinosinusitis With Polyps
협력: 사노피
상세 →NCT06556264
단계 미표기모집 예정· Gaucher Disease
Screening for Gaucher Disease and Acid Sphingomyelinase Deficiency
협력: 사노피
상세 →NCT06258577

BioPulse가 제공하는 정보는 공개된 자료를 요약·정리한 것으로, 투자 조언이나 의료 조언이 아닙니다. 임상 데이터·규제 일정·공시 내용은 반드시 원문을 직접 확인하시기 바랍니다.